13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001879713
Total reported value
$243.3M
$243.3M
68 檔
29.5%
In Q2 2024, Tejara Capital Ltd's U.S. equity holdings reached a combined market value of $243.3M, distributed across 68 disclosed stock positions.
During Q2 2024, Tejara Capital Ltd's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ROIV, HRTX, ARQT) accounted for 29.5% of total reported equity market value during Q2 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 8.39% | — | -16.01% | |
| 2 | HRTX | Heron Therapeutics Inc | Stock-Other | 5.33% | -0.53% | -5.07% | |
| 3 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 4.54% | -0.07% | +42.86% | |
| 4 | LBTYA | Liberty Global Ltd. | Stock-Other | 4.06% | -0.77% | EXIT | |
| 5 | RIG | Transocean Ltd. | Stock-Energy | 3.77% | — | +67.74% | |
| 6 | NOV | Nov Inc | Stock-Energy | 3.73% | -1.37% | EXIT | |
| 7 | BORR | Borr Drilling Limited | Stock-Other | 3.61% | +0.25% | +19.07% | |
| 8 | NBR | Nabors Industries Ltd. | Stock-Other | 3.61% | — | +8.56% | |
| 9 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 3.42% | +0.05% | +5.88% | |
| 10 | GPN | Global Payments Inc | Stock-Industrials | 3.34% | +0.42% | — | |
| 11 | SLV | Ishares Silver Trust | ETF-Commodities | 2.99% | — | +106.67% | |
| 12 | BGC | Bgc Group Inc-a | Stock-Financials | 2.70% | — | +6.54% | |
| 13 | VTRS | Viatris Inc | Stock-Healthcare | 2.70% | -2.69% | EXIT | |
| 14 | CRC | California Resources CORP | Stock-Energy | 2.54% | — | — | |
| 15 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 2.47% | — | -46.35% | |
| 16 | DFSEUR | Discover Financial Services | Stock-Other | 2.40% | — | — | |
| 17 | NE | Noble Corporation plc | Stock-Energy | 2.36% | +0.31% | +60.81% | |
| 18 | NXE | Nexgen Energy LTD | Stock-Other | 2.18% | — | +72.90% | |
| 19 | REKR | Rekor Systems Inc | Stock-Other | 2.11% | — | +14.07% | |
| 20 | OFIX | Orthofix Medical Inc | Stock-Other | 2.10% | +0.07% | — | |
| 21 | GEO | Geo Group Inc/the | Stock-Other | 1.99% | -1.18% | EXIT | |
| 22 | BTU | Peabody Energy CORP | Stock-Energy | 1.82% | — | +32.21% | |
| 23 | MD | Pediatrix Medical Group Inc | Stock-Other | 1.65% | — | — | |
| 24 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 1.46% | -0.84% | EXIT | |
| 25 | SLCAUSD | US Silica Holdings Inc | Stock-Other | 1.42% | — | +60.13% | |
| 26 | SSYS | Stratasys Ltd. | Stock-Other | 1.39% | -0.79% | EXIT | |
| 27 | SLB | Slb LTD | Stock-Energy | 1.34% | -1.31% | +291.99% | |
| 28 | FET | Forum Energy Technologies In | Stock-Other | 1.34% | — | +2.57% | |
| 29 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 1.26% | -0.05% | +4.73% | |
| 30 | ADPT | Adaptive Biotechnologies | Stock-Other | 1.20% | — | +237.92% | |
| 31 | XPER | Xperi Inc | Stock-Other | 1.12% | — | +84.60% | |
| 32 | SCPH | Scpharmaceuticals Inc | Stock-Other | 1.11% | — | +0.94% | |
| 33 | 0C3 | Endeavor Group Hold-class A | Stock-Other | 0.98% | — | — | |
| 34 | RNW | ReNew Energy Global Plc | Stock-Other | 0.98% | -0.39% | EXIT | |
| 35 | DNN | Denison Mines CORP | Stock-Other | 0.96% | — | — | |
| 36 | ZYME | Zymeworks Inc | Stock-Other | 0.84% | — | +28.54% | |
| 37 | CSTM | Constellium SE | Stock-Other | 0.72% | — | +248.33% | |
| 38 | SDGR | Schrodinger Inc | Stock-Other | 0.71% | +0.41% | — | |
| 39 | BIDU | Baidu Inc - Spon Adr | Stock-Comm Services | 0.68% | — | +125.00% | |
| 40 | CHRS | Coherus Oncology Inc | Stock-Other | 0.65% | — | -2.37% | |
| 41 | BP | Bp Plc-spons Adr | Stock-Energy | 0.64% | — | — | |
| 42 | HAL | Halliburton Co | Stock-Energy | 0.61% | — | — | |
| 43 | QDEL | Quidelortho CORP | Stock-Other | 0.54% | -0.23% | -36.57% | |
| 44 | IMVT | Immunovant Inc | Stock-Other | 0.53% | — | — | |
| 45 | FIP | Ftai Infrastructure Inc | Stock-Other | 0.53% | -0.74% | EXIT | |
| 46 | TSAT | Telesat CORP | Stock-Other | 0.52% | — | -5.94% | |
| 47 | MATV | Mativ Holdings Inc | Stock-Other | 0.52% | — | -32.56% | |
| 48 | OSG | Octave Specialty Group Inc | Stock-Other | 0.47% | — | — | |
| 49 | TRVI | Trevi Therapeutics Inc | Stock-Other | 0.44% | — | +983.18% | |
| 50 | OPK | Opko Health Inc | Stock-Other | 0.41% | -0.33% | EXIT |
According to official SEC Form 13F filings, Tejara Capital Ltd reported a total U.S. public equity portfolio value of $243.3M across 68 disclosed positions in Q2 2024.
During Q2 2024, Tejara Capital Ltd's top holdings by market value included ROIV (8.4%)、HRTX (5.3%)、ARQT (4.5%). The largest single position, ROIV, represented 8.4% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q2 2024, Tejara Capital Ltd made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.